PTN:Palatin Technologies Inc Snapshot | Charting | News | Options
$2.05   0.00%  $0.00 NYSE MKT LLC 7:30a ET
April 8 '24 		Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at America... PR Newswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story Top Stories on PTN
    No News Available
    Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical...
    7:30a ET February 28 '24 PR Newswire
    Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and...
    7:30a ET February 15 '24 PR Newswire
    Palatin to Report Second Quarter Fiscal Year 2024 Results; Teleconfer...
    7:30a ET February 9 '24 PR Newswire

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.